Concentrations of Gd-BOPTA in cholestatic fatty rat livers: Role of transport functions through membrane proteins

Contrast Media and Molecular Imaging

Volumn 8, Issue 2, 2013, Pages 147-156

  Pastor, Catherine M ^a   Wissmeyer, Michael ^b   Millet, Philippe ^c  

^a Laboratoire de Physiopathologie Hépatique et Imagerie Moléculaire   (Switzerland)

^b HÔpital de La Tour   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Cellular transport; Liver MRI; MR hepatobiliary contrast agent

Indexed keywords

GADOBENIC ACID; MEMBRANE PROTEIN;

ANIMAL CELL; ARTICLE; BILE FLOW; CELL TRANSPORT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FATTY LIVER; LIVER CELL; LIVER PERFUSION; LIVER SINUSOID; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; RAT; SIMULATION;

ANIMALS; CHOLESTASIS, INTRAHEPATIC; COMPUTER SIMULATION; CONTRAST MEDIA; FATTY LIVER; LIVER; MEGLUMINE; MEMBRANE TRANSPORT PROTEINS; METABOLIC CLEARANCE RATE; MODELS, BIOLOGICAL; ORGANOMETALLIC COMPOUNDS; RATS; RATS, ZUCKER; TISSUE DISTRIBUTION;

EID: 84871658261     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.1511     Document Type: Article

References (30)

1. Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 2010; 51: 679-689.
2. Arrese M, Trauner M. Molecular aspects of bile formation and cholestasis. Trends Mol Med 2003; 9: 558-564.
3. Arrese M, Karpen SJ. Nuclear receptors, inflammation, and liver disease: insights for cholestatic and fatty liver diseases. Clin Pharmacol Ther 2010; 87: 473-478.
4. Wagner M, Zollner G, Trauner M. New molecular insights into the mechanisms of cholestasis. J Hepatol 2009; 51: 565-580.
5. Zollner G, Wagner M, Trauner M. Nuclear receptors as drug targets in cholestasis and drug-induced hepatotoxicity. Pharmacol Ther 2010; 126: 228-243.
6. Lickteig AJ, Fisher CD, Augustine LM, Aleksunes LM, Besselsen DG, Slitt AL, Manautou JE, Cherrington NJ. Efflux transporter expression and acetaminophen metabolite excretion are altered in rodent models of nonalcoholic fatty liver disease. Drug Metab Dispos 2007; 35: 1970-1978.
7. Ma X, Holalkere NS, Kambadakone RA, Mino-Kenudson M, Hahn PF, Sahani DV. Imaging-based quantification of hepatic fat: methods and clinical applications. Radiographics 2009; 29: 1253-1277.
8. Reeder SB, Cruite I, Hamilton G, Sirlin CB. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imag 2011; 34: 729-749.
9. Springer F, Machann J, Claussen CD, Schick F, Schwenzer NF. Liver fat content determined by magnetic resonance imaging and spectroscopy. World J Gastroenterol 2010; 16: 1560-1566.
10. Marin D, Iannaccone R, Catalano C, Passariello R. Multinodular focal fatty infiltration of the liver: atypical imaging findings on delayed T1-weighted Gd-BOPTA-enhanced liver-specific MR images. J Magn Reson Imag 2006; 24: 690-694.
11. Tsuda N, Okada M, Murakami T. New proposal for the staging of nonalcoholic steatohepatitis: evaluation of liver fibrosis on Gd-EOB-DTPA-enhanced MRI. Eur J Radiol 2010; 73: 137-142.
12. Yamamoto A, Tamada T, Sone T, Higashi H, Yamashita T, Ito K. Gd-EOB-DTPA-enhanced magnetic resonance imaging findings of nondiffuse fatty change of the liver. J Comput Assist Tomogr 2010; 34: 868-873.
13. Millet P, Moulin M, Stieger B, Daali Y, Pastor CM. How organic anions accumulate in hepatocytes lacking Mrp2: evidence in rat liver. J Pharmacol Exp Ther 2011; 336: 624-632.
14. Planchamp C, Hadengue A, Stieger B, Bourquin J, Vonlaufen A, Frossard J-L, Quadri R, Becker CD, Pastor CM. Function of both sinusoidal and canalicular transporters controls the concentration of organic anions within hepatocytes. Mol Pharmacol 2007; 71: 1089-1097.
15. de Haën C, Lorusso V, Tirone P. Hepatic transport of gadobenate dimeglumine in TR- rats. Acad Radiol 1996; 3: S452-S454.
16. Planchamp C, Montet X, Frossard J-L, Quadri R, Stieger B, Meier PJ, Ivancevic MK, Vallée J-P, Terrier F, Pastor CM. Magnetic resonance imaging with hepatospecific contrast agents in cirrhotic rat livers. Invest Radiol 2005; 40: 187-194.
17. Geier A, Dietrich CG, Grote T, Beuers U, Prüfer T, Fraunberger P, Matern S, Gartung C, Gerbes AL, Bilzer M. Characterization of organic anion transporter regulation, glutathione metabolism and bile formation in the obese Zucker rat. J Hepatol 2005; 43: 1021-1030
18. Kim MS, Wang S, Shen Z, Kochansky CJ, Strauss JR, Franklin RB, Vincent SH. Differences in the pharmacokinetics of peroxisome proliferator-activated receptor agonists in genetically obese Zucker and Sprague-Dawley rats: implications of decreased glucuronidation in obese Zucker rats. Drug Metab Dispos 2004; 32: 909-914.
19. Pizarro M, Balasubramaniyan N, Solís N, Solar A, Duarte I, Miquel JF, Suchy FJ, Trauner M, Accatino L, Ananthanarayanan M, Arrese M. Bile secretory function in the obese Zucker rat: evidence of cholestasis and altered canalicular transport function. Gut 2004; 53: 1837-1843.
20. Planchamp C, Gex-Fabry M, Becker CD, Pastor CM. Model-based analysis of Gd-BOPTA-induced MR signal intensity changes in cirrhotic rat livers. Invest Radiol 2007; 42: 513-521.
21. 153Gd-BOPTA. Invest Radiol 2005; 40: 705-714.
22. Dombrowski F, Kubitz R, Chittattu A, Wettstein M, Saha N, Haussinger D. Electron-microscopic demonstration of multidrug resistance protein 2 (Mrp2) retrieval from the canalicular membrane in response to hyperosmolarity and lipopolysaccharide. Biochem J 2000; 348: 183-188.
23. Beuers U, Bilzer M, Chittattu A, Kullak-Ublick GA, Keppler D, Paumgartner G, Dombrowski F. Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver. Hepatology 2001; 33: 1206-1216.
24. Pastor CM, Planchamp C, Pochon S, Lorusso V, Montet X, Mayer J, Terrier F, Vallée J-P. Kinetics of gadobenate dimeglumine in isolated perfused rat liver: MR imaging evaluation. Radiology 2003; 229: 119-125.
25. Tsuda N, Matsui O. Signal profile on Gd-EOB-DTPA-enhanced MR imaging in non-alcoholic steatohepatitis and liver cirrhosis induced in rats: correlation with transporter expression. Eur Radiol 2011; 21: 2542-2550.
26. Planchamp C, Beyer GJ, Slosman DO, F Terrier F, Pastor CM. Direct evidence of the temperature dependence of Gd-BOPTA transport in the intact liver. Appl Radiat Isot 2005; 62: 943-949.
27. Chandra P, Johnson BM, Zhang P, Pollack GM, Brouwer KL. Modulation of hepatic canalicular or basolateral transport proteins alters hepatobiliary disposition of a model organic anion in the isolated perfused rat liver. Drug Metab Dispos 2005; 33: 1238-1243.
28. Ghibellini G, Leslie EM, Pollack GM, Brouwer KL. Use of Tc-99m mebrofenin as a clinical probe to assess altered hepatobiliary transport: integration of in vitro, pharmacokinetic modeling, and simulation studies. Pharm Res 2008; 25: 1851-1860.
29. Bhargava KK, Joseph B, Ananthanarayanan M, Balasubramaniyan N, Tronco GG, Palestro CJ, Gupta S. Adenosine triphosphate-binding cassette subfamily C member 2 is the major transporter of the hepatobiliary imaging agent (99m)Tc-mebrofenin. J Nucl Med 2009; 50: 1140-1146.
30. de Graaf W, Bennink RJ, Heger M, Maas A, de Bruin K, van Gulik TM. Quantitative assessment of hepatic function during liver regeneration in a standardized rat model. J Nucl Med 2011; 52: 294-302.